Atria Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $202K | Sell |
1,596
-664
| -29% | -$84K | ﹤0.01% | 1923 |
|
2025
Q1 | $289K | Buy |
2,260
+532
| +31% | +$68K | ﹤0.01% | 1637 |
|
2024
Q4 | $228K | Buy |
1,728
+28
| +2% | +$3.7K | ﹤0.01% | 1725 |
|
2024
Q3 | $248K | Sell |
1,700
-315
| -16% | -$45.9K | ﹤0.01% | 1716 |
|
2024
Q2 | $277K | Buy |
+2,015
| New | +$277K | ﹤0.01% | 1636 |
|
2020
Q3 | – | Sell |
-8,197
| Closed | -$1.12M | – | 590 |
|
2020
Q2 | $1.12M | Buy |
+8,197
| New | +$1.12M | 0.04% | 477 |
|
2020
Q1 | – | Sell |
-2,467
| Closed | -$297K | – | 831 |
|
2019
Q4 | $297K | Buy |
+2,467
| New | +$297K | 0.01% | 979 |
|
2018
Q4 | – | Sell |
-3,115
| Closed | -$380K | – | 940 |
|
2018
Q3 | $380K | Buy |
+3,115
| New | +$380K | 0.02% | 687 |
|
2018
Q1 | – | Sell |
-2,322
| Closed | -$248K | – | 888 |
|
2017
Q4 | $248K | Sell |
2,322
-4,173
| -64% | -$446K | 0.01% | 714 |
|
2017
Q3 | $722K | Buy |
+6,495
| New | +$722K | 0.04% | 380 |
|
2016
Q4 | – | Sell |
-6,768
| Closed | -$653K | – | 652 |
|
2016
Q3 | $653K | Buy |
+6,768
| New | +$653K | 0.06% | 268 |
|
2016
Q1 | – | Sell |
-8,085
| Closed | -$814K | – | 458 |
|
2015
Q4 | $814K | Buy |
8,085
+2,319
| +40% | +$233K | 0.09% | 171 |
|
2015
Q3 | $583K | Buy |
5,766
+666
| +13% | +$67.3K | 0.08% | 173 |
|
2015
Q2 | $627K | Sell |
5,100
-273
| -5% | -$33.6K | 0.07% | 200 |
|
2015
Q1 | $615K | Sell |
5,373
-156
| -3% | -$17.9K | 0.07% | 211 |
|
2014
Q4 | $559K | Buy |
5,529
+72
| +1% | +$7.28K | 0.06% | 235 |
|
2014
Q3 | $498K | Sell |
5,457
-1,560
| -22% | -$142K | 0.05% | 276 |
|
2014
Q2 | $601K | Sell |
7,017
-1,467
| -17% | -$126K | 0.06% | 249 |
|
2014
Q1 | $669K | Buy |
8,484
+1,266
| +18% | +$99.8K | 0.07% | 239 |
|
2013
Q4 | $546K | Buy |
7,218
+1,269
| +21% | +$96K | 0.05% | 276 |
|
2013
Q3 | $416K | Sell |
5,949
-9
| -0.2% | -$629 | 0.04% | 309 |
|
2013
Q2 | $345K | Buy |
+5,958
| New | +$345K | 0.04% | 259 |
|